1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow NL201: new trials by email Literature Review of NL201 trials Research Report on NL201
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11 NL201, rhIL-11 - Chemotherapy-induced Thrombocytopenia | Phase 3 | Completed | Beijing Northland Biotech. Co., Ltd. | 62 | 2015-03-01 | 2020-09-16 |
Thrombocytopenia (1)
Beijing Northland Biotech. Co., Ltd. (1)
China (1)